Creon Capsule, Delayed Release Pellets
Product Images NDC 0032-1212

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Creon (NDC 0032-1212). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 0032-0045-7070 Delayed-release Capsulesrx Onlypancrelipasecreon®delayed-release Capsulesdose By Lipase Units Lipase 3,000 Usp Units Protease 9,500 Usp Units Amylase 15,000 Usp Unitseach Delayed-release Capsule Containspancrelipase In Enteric-coated Spheres.dispense Enclosed Medication Guide To Each Patient. (Creon Pancrelipase Delayed Release Caps 01)

Creon pancrelipase delayed-release capsules label showing the 70-count package. The label lists enzyme dosages per capsule as 3,000 USP Units Lipase, 9,500 USP Units Protease, and 15,000 USP Units Amylase. The label includes storage instructions, usage warnings, and the manufacturer AbbVie Inc. The NDC code 0032-0045-70 is visible along with barcodes and lot information.*

FDA Label Image

Ndc 0032-0046-70100 Delayed-release Capsulesrx Onlypancrelipasecreon®delayed-release Capsulesdose By Lipase Units Lipase 6,000 Usp Units Protease 19,000 Usp Units Amylase 30,000 Usp Unitseach Delayed-release Capsule Containspancrelipase In Enteric-coated Spheres.dispense Enclosed Medication Guide To Each Patient. (Creon Pancrelipase Delayed Release Caps 02)

The labeling for Creon delayed-release capsules features pancrеlipase as the active ingredient. It specifies dosing by lipase units, showing 6,000 USP Units for lipase, 19,000 USP Units for protease, and 30,000 USP Units for amylase. The label includes medication storage instructions, warnings against crushing or chewing capsules, and advises dispensing the enclosed Medication Guide. The labeler is AbbVie Inc.*

FDA Label Image

Ndc 0032-0047-70100 Delayed-release Capsulesrx Onlypancrelipasecreon®delayed-release Capsulesdose By Lipase Units Lipase 12,000 Usp Units Protease 38,000 Usp Units Amylase 60,000 Usp Unitseach Delayed-release Capsule Containspancrelipase In Enteric-coated Spheres.dispense Enclosed Medication Guide To Each Patient. (Creon Pancrelipase Delayed Release Caps 03)

Label for Creon delayed-release capsules containing pancrelipase with lipase 12,000 USP units, protease 38,000 USP units, and amylase 60,000 USP units per capsule. The label displays the NDC 0032-0047-70, indicates 100 capsules, and includes warnings not to crush or chew the capsules. It advises storage at 15°C to 25°C (59°F to 77°F), keeping the bottle tightly closed and out of reach of children. Manufactured by AbbVie Inc., North Chicago, IL.*

FDA Label Image

Ndc 0032-1203-70 70 Delayed-release Capsules Pancrelipasecreon® Delayed-release Capsules Dose By Lipase Units Lipase 3,000 Usp Units Protease 9,500 Usp Units Amylase 15,000 Usp Units Each Delayed-release Capsulecontains Pancrelipase In Enteric-coated Spheres. Dispense Enclosed Medication Guide To Each Patient.rx Only Abbvie (Creon Pancrelipase Delayed Release Caps 04)

Creon delayed-release capsules containing pancrelipase with Lipase 3,000 USP units, Protease 9,500 USP units, and Amylase 15,000 USP units. The label indicates a package of 70 capsules by AbbVie Inc., with storage instructions and warnings about bottle seal integrity and swallowing capsules whole. The label also notes the presence of an enclosed Medication Guide and a prescription-only status.*

FDA Label Image

Ndc 0032-1206-01100 Delayed-release Capsules Pancrelipase Creon® Delayed-release Capsules Dose By Lipase Units Lipase 6,000 Usp Unitsprotease 19,000 Usp Unitsamylase 30,000 Usp Units Each Delayed-release Capsule Contains Pancrelipase In Enteric-coated Spheres. Dispense Enclosed Medicationguide To Each Patient.rx Only Abbvie (Creon Pancrelipase Delayed Release Caps 05)

The image shows the packaging label for Creon delayed-release capsules containing pancrelipase. The label indicates a dosage strength of Lipase 6,000 USP units, Protease 19,000 USP units, and Amylase 30,000 USP units per capsule. It includes storage instructions, a warning not to crush or chew the capsules, and advises dispensing enclosed Medication Guide to each patient. The label identifies AbbVie Inc. as the labeler and provides an NDC of 0032-1206-01 for a package of 100 capsules.*

FDA Label Image

Ndc 0032-1212-07250 Delayed-release Capsules Pancrelipase Creon® Delayed-release Capsules Dose By Lipase Units Lipase 12,000 Usp Units Protease 38,000 Usp Units Amylase 60,000 Usp Units Each Delayed-release Capsule Contains Pancrelipase In Enteric-coated Spheres. Dispense Enclosed Medication Guide To Each Patient.rx Only Abbvie (Creon Pancrelipase Delayed Release Caps 06)

Label for Creon delayed-release capsules containing pancrelipase by AbbVie Inc. The label shows a 250 count package with enzyme activity doses: Lipase 12,000 USP units, Protease 38,000 USP units, and Amylase 60,000 USP units per capsule. It includes storage instructions and warnings against crushing or chewing the capsules.*

FDA Label Image

Ndc 0032-1224-01100 Delayed-release Capsules Pancrelipase Creon® Delayed-release Capsules Dose By Lipase Units Lipase 24,000 Usp Units Protease 76,000 Usp Units Amylase 120,000 Usp Units Each Delayed-release Capsule Contains Pancrelipase In Enteric-coated Spheres. Dispense Enclosed Medication Guide To Each Patient.rx Only Abbvie (Creon Pancrelipase Delayed Release Caps 07)

Label for Creon delayed-release capsules containing pancrelipase with enzyme strengths of 24,000 USP units for lipase, 76,000 USP units for protease, and 120,000 USP units for amylase. The label includes storage instructions, warning not to crush or chew capsules, and dispensing information. The product is manufactured by AbbVie Inc. in North Chicago, IL, and comes in a 100-count package.*

FDA Label Image

Ndc 0032-2636-70240 Delayed-release Capsulespancrelipasecreon®delayed-release Capsulesdose By Lipase Unitslipase 24,000 Usp Unitsprotease 76,000 Usp Unitsamylase 120,000 Usp Unitseach Delayed-release Capsule Containspancrelipase In Enteric-coated Spheres.dispense Enclosed Medication Guide To Each Patient.rx Onlyabbvie (Creon Pancrelipase Delayed Release Caps 08)

Creon 24,000 USP Units delayed-release capsules containing pancrelipase active ingredients lipase, protease, and amylase. The label shows dosage form as delayed-release capsules with pancrelipase in enteric-coated spheres, manufactured by AbbVie Inc. Includes warnings not to crush or chew and storage instructions to keep at 15°C to 25°C (59°F to 77°F) and protect from moisture. Package contains 240 capsules.*

FDA Label Image

Ndc 0032-2637-70240 Delayed-release Capsulespancrelipasecreon®delayed-release Capsulesdose By Lipase Unitslipase 36,000 Usp Unitsprotease 114,000 Usp Unitsamylase 180,000 Usp Uniteseach Delayed-release Capsule Containspancrelipase In Enteric-coated Spheres.dispense Enclosed Medication Guide To Each Patient.rx Onlyabbvie (Creon Pancrelipase Delayed Release Caps 09)

Label for Creon delayed-release capsules containing pancrelipase with enzyme strengths of 36,000 USP units Lipase, 114,000 USP units Protease, and 180,000 USP units Amylase per capsule. The label includes the NDC 0032-2637-70 with 240 capsules, manufacturer AbbVie Inc., storage instructions, and a warning not to crush or chew the capsule contents.*

FDA Label Image

Ndc 0032-3016-13100 Delayed-release Capsulespancrelipasecreon®delayed-release Capsulesdose By Lipase Units Lipase 36,000 Usp Units Protease 114,000 Usp Units Amylase 180,000 Usp Units Each Delayed-release Capsule Contains Pancrelipase In Enteric-coated Spheres. Dispense Enclosed Medication Guide To Each Patient.rx Only Abbvie (Creon Pancrelipase Delayed Release Caps 0a)

Packaging label for Creon delayed-release capsules containing pancrelipase. The label specifies strength with Lipase 36,000 USP units, Protease 114,000 USP units, and Amylase 180,000 USP units per capsule. It includes directions about storage at room temperature 15°C to 25°C, warnings not to crush or chew capsules, and dispensing instructions. The label shows the NDC number 0032-3016-13 and is manufactured by AbbVie Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.